Clinical Trial

Esketamine Combined With PRF of DRG for Acute/Subacute Zoster-associated Pain

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess the 1-month effects and safety of esketamine - PRF -standardized drug treatment against PRF -standardized drug treatment acute/subacute zoster-associated pain (ZAP) patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-31.
Trial Details
NCT Number NCT06914206
Lead Sponsor Beijing Tiantan Hospital
Collaborators: Beijing Xiaotangshan Hospital, The First Hospital of Fangshan District,Beijing, Beijing Ditan Hospital, Hengshui People's Hospital
Conditions Herpes Zoster
Enrollment 184 participants
Start Date 2025-04-01
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-09